What is GridAI Technologies Corp. (GRDX)?

GridAI Technologies Corp. (GRDX) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of GRDX?

The current price of GRDX is $5.45. Prices are updated in real time on Stocks360.

What is GRDX's price-to-earnings (PE) ratio?

GRDX's trailing twelve-month PE ratio is -1.26, based on current price and earnings per share data available on Stocks360.

What is GRDX's market capitalization?

GRDX's market capitalization is $38,864,620.00, placing it in the small-cap tier.

GridAI Technologies Corp. (GRDX)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$5.45

Market Cap

$38.86M

PE (TTM)

-1.26

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.70

Day Range

$5.15 – $5.70

52-wk Range

$1.87 – $6.93

Avg Volume

N/A

Volume

198.75K

GridAI Technologies Corp. (GRDX) is a publicly traded company in the Healthcare sector. Latest price: $5.45. Market cap $38.86M. Trailing PE -1.26. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $4.43 2026-10-29 · $5.45 (+23.02%)

Earnings

Most Recent

Aug 21, 2026

EPS $-0.44 vs est. $-11340.00

Beat by $11339.56

Next Earnings

Nov 16, 2026

EPS estimate $-11340.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About GridAI Technologies Corp.

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-1.26×
P/S (TTM)	242.40×
P/B	1.91×
PEG	0.02×
P/FCF (TTM)	-4.79×
EV / EBITDA	-3.87×
EV / Sales	245.09×
Earnings Yield	-58.61%
Free Cash Flow Yield	-20.90%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$39.30M
Revenue (TTM)	$160.34K
Net Income (TTM)	-$22.78M
Free Cash Flow (TTM)	-$6.82M
Net Debt	$432.25K
Working Capital	-$11.85M
Gross Margin	-1532.49%
Operating Margin	-7655.42%
Net Margin	-12789.65%
Return on Equity	-55.12%
Return on Invested Capital	-40.78%